Filter
3940
Filtered Results: 3940
Text search:
drug
distribution
Featured
Recommendations
320
New Publications
1161
Language
Document type
No document type
2502
Studies & Reports
602
Guidelines
454
Manuals
147
Strategic & Response Plan
120
Fact sheets
41
Training Material
39
Situation Updates
22
Infographics
8
Brochures
2
Resource Platforms
2
Online Courses
1
Countries / Regions
India
212
Kenya
127
Global
119
Uganda
106
Ethiopia
101
Nigeria
96
South Africa
82
Sierra Leone
76
Liberia
76
Nepal
73
Western and Central Europe
73
Malawi
71
Tanzania
67
Zambia
61
Myanmar / Burma
60
Ghana
58
Latin America and the Carribbean
58
Bangladesh
55
Rwanda
54
Africa
50
Ukraine
43
Namibia
42
Eastern Europe
37
Zimbabwe
36
Philippines
35
Cambodia
31
Lesotho
30
South–East Asia Region
27
Asia
26
Senegal
25
Botswana
23
Congo, Democratic Republic of
20
Indonesia
20
Russia
20
Burkina Faso
19
Mozambique
19
Colombia
16
East and Southern Africa
16
Syria
15
Haiti
14
Eswatini/ Swaziland
13
Venezuela
12
USA
11
South Sudan
11
West and Central Africa
11
Paraguay
11
Albania
11
Cameroon
10
Thailand
10
Middle East and North Africa
10
Benin
9
Brazil
9
Guinea
8
Pakistan
8
Germany
8
Peru
8
Eastern Europe and Central Asia
8
Tajikistan
8
Sudan
7
Argentina
7
Georgia
7
Moldova
6
Vietnam
6
Iraq
5
Afghanistan
5
North Macedonia
5
Bolivia
5
Laos
5
China
4
El Salvador
4
Sri Lanka
4
Chile
4
Armenia
4
Spain
4
Morocco
3
Jordan
3
Lebanon
3
Turkey
3
Papua New Guinea
3
Western Pacific Region
3
Bhutan
3
Timor Leste/ East Timor
3
Central African Republic
2
Honduras
2
Libya
2
Madagascar
2
Mexico
2
Yemen
2
Fiji
2
Mongolia
2
Southern Africa
2
Iran
2
Uzbekistan
2
Kyrgyzstan
2
North America
2
Gabon
2
Uruguay
2
Tunisia
2
United Kingdom
2
Portugal
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Egypt
1
Chad
1
Ireland
1
Serbia
1
Hungary
1
Ecuador
1
Greece
1
Angola
1
Guatemala
1
Nicaragua
1
Palestine
1
North Korea
1
Canada
1
Bulgaria
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Jamaica
1
France
1
Maldives
1
Mauritius
1
Norway
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1656
Clinical Guidelines
341
Public Health
205
Women & Child Health
141
Key Resources
77
Pharmacy & Technologies
57
Capacity Building
48
Annual Report MEDBOX
1
Toolboxes
HIV
433
Mental Health
345
TB
317
AMR
189
COVID-19
156
NTDs
156
Pharmacy
146
Rapid Response
69
Caregiver
62
Planetary Health
60
NCDs
58
Ebola
49
Refugee
48
Disability
45
Conflict
44
Global Health Education
41
Health Financing Toolbox
26
Natural Hazards
20
Polio
15
Specific Hazards
15
Cholera
14
Zika
14
Social Ethics
7
Health Financing
1
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time could induce resistance to antibiotics,
putting p...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
This new guidance aims to support programme implementers, coordinators and others in humanitarian settings in their actions to counter suicide and self-harm in humanitarian contexts and to save lives.
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
A 7.7 magnitude earthquake struck at 04:17 local time on 6 February 2023, with its epicentre located in Pazarcık district
in Kahramanmaraş province, Türkiye. Over 1200 aftershocks have since been reported. These are Türkiye’ s most powerful
earthquakes since 1939
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
The purpose of this guide is to provide practical advice for health staff undertaking infectious disease preparedness and response activities to ensure that access to safe abortion care (SAC) is maintained when an infectious disease outbreak occurs. It is an operational guide which can serve to supp...
Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public
health hazard often faced by rural population in tropical and subtropical countries with heavy
rainfall and humid climate.
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
